Would you want a “Smart” Bra? I am reposting an article which I saw on New Beauty…the original post can be found here:
Brittany Burhop , Senior Editor | January 06, 2016
Tech-wellness company OMsignal is launching a new sports bra that’s sparking quite a buzz in the fitness world.
Created over the course of a year by sports bra designers, scientists and engineers (they developed 1633 prototypes before getting it exactly right), the OMbra changes the way you approach your workouts. Here’s how: Flexible sensors are built into the bra to track your body’s activity levels using real-time biometrics (including heart rate and breathing rhythm) to keep you on track during workouts. Whether you push too hard for what your body can handle or you aren’t maximizing your potential, the OMbra will signal and help you adjust.
Plus, in addition to the high-tech science behind it, it’s designed to provide ultimate comfort and flexibility—the straps are adjustable to fit different body types and the fabric is lightweight and super stretchable with antimicrobial and sweat-wicking properties. Mesh panels on the front and back help enhance breathability.
“I love the idea for this bra. Its functional and innovative, it looks like it’s comfortable, and the best part is that it holds you accountable for your actions,” says celebrity trainer Ramona Braganza. “To me, its best feature is that it allows you to monitor your breathing during workouts, as well as every day, which helps to reduce stress. That makes it a valuable health tool.”
Set to hit the market in April/May, the OMbra kit will sell for $149 and will include a charging cable (you’ll get about 10 workouts in before you have to recharge).
I am reposting an article from New Beauty here…the original post can be found at:
Liz Ritter , Executive Managing Editor | January 07, 2016
Still hot off the heels of its historic merger at the end of last year with Pfizer, Allergan announced today that it will purchase Anterios, Inc., a clinical-stage biopharmaceutical company that is developing what they refer to as “a next-generation delivery system and botulinum toxin–based prescription products.”
It all sounds very futuristic, but what makes this particularly interesting is that Allergan (which is best-known as being the maker of Botox) will now be in business with a company that has a “proprietary platform delivery technology that enables local, targeted delivery of neurotoxins through the skin without the need for injections.” In other words, something that sounds a lot like a topical type of Botox.
According to the official Allergan release, executive vice president David Nicholson said the acquisition “demonstrates our ability to apply our tremendous scientific leadership in neurotoxins to further extend our already deep neurotoxin pipeline by advancing a new delivery system and formulations that are appealing to both patients and physicians.”
“Allergan is once again showing their commitment to aesthetics by purchasing Anterios and acquiring the global rights to ANT–1207,” Montclair, NJ, dermatologist Jeanine B. Downie, MD, says. “The absolutely awesome potential of these two products is thrilling for patients that are looking for non-invasive approach is to treat their aesthetic and dermatologic conditions. An enhanced delivery system would be of great interest to physicians, as well as to the general public. I do believe these acquisitions will bring more people that are considering cosmetic procedures into their doctors’ offices for treatment.”